STANDARD BIOTOOLS INC (LAB:NASDAQ)
$0.9184 -0.0194 (-2.0687%)
Analysed STANDARD BIOTOOLS INC (LAB:NASDAQ) News Sources
Structure Therapeutics Stock Surges 200% This Past Year as One Fund Cuts Stake by $15.5 Million
27-02-2026
fool.com
Relay Therapeutics Stock Up 235% This Past Year as One Fund Lifts Bet to $110 Million
27-02-2026
fool.com
Labrador Gold Announces Closing of Change of Business and Acquisition of Units of Northern Shield
09-03-2026
yahoo.com
Labrador Gold Welcomes Recent Announcement by the Ontario Government Concerning Accelerated Development of the Ring of Fire Road
26-03-2026
yahoo.com
Standard BioTools (LAB) is One of the Best Life Sciences Penny Stocks, Here is Why
14-04-2026
yahoo.com
Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026
21-04-2026
yahoo.com
Standard BioTools Reports First Quarter 2026 Financial Results
05-05-2026
yahoo.com
Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates
06-05-2026
yahoo.com
Standard BioTools and Treeline Biosciences Announce Merger Agreement
08-06-2026
yahoo.com
Stealthy startup Treeline plans a reverse merger
09-06-2026
biopharmadive.com
What is the current price of STANDARD BIOTOOLS INC (LAB:NASDAQ)?
The current price of STANDARD BIOTOOLS INC (LAB:NASDAQ) is $0.9184.
STANDARD BIOTOOLS INC (LAB:NASDAQ) absolute price change since previous trading day?
The absolute price change of STANDARD BIOTOOLS INC (LAB:NASDAQ) since the previous trading day is $-0.0194.
STANDARD BIOTOOLS INC (LAB:NASDAQ) percentage price change since previous trading day?
The percentage price change of STANDARD BIOTOOLS INC (LAB:NASDAQ) since the previous trading day is -2.0687%.
What is the most recent average sentiment score for STANDARD BIOTOOLS INC (LAB:NASDAQ)?
The most recent average sentiment score for STANDARD BIOTOOLS INC (LAB:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for STANDARD BIOTOOLS INC (LAB:NASDAQ)?
The most recent sentiment for STANDARD BIOTOOLS INC (LAB:NASDAQ) is .
SEC-8K** Filing Available For STANDARD BIOTOOLS INC (LAB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.